ADVERTISEMENT
Bharat Biotech unveils world’s first intranasal COVID-19 vaccine ‘iNCOVACC’
iNCOVACC is a cost-effective vaccine that utilizes a vector-based platform, which can be easily updated with emerging variants leading to large-scale production.
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login